Healthcare provider profile · identity verified

David Milbauer, MD

Allopathic & Osteopathic Physicians|Internal Medicine · LAKE WORTH, FL · NPI 1497727432

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show David Milbauer, MD received $13.94 in general payments during 2025 across 1 reported records.

Amgen Inc. accounted for 100.0% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 2 associated products.

Amgen Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported PROLIA as an associated drug or biological on 20867 records involving 11744 distinct recipient NPIs. Public Medicare Part D data also shows 19 claims for Prolia by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$13.94

1 reported records · 1 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Amgen Inc.	Unresolved — no canonical attribution shown	$13.94	100.0%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$13.94	1

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
OTEZLA Normalized: otezla	Drug	Amgen Inc.	$13.94	1	2025
Source payment records 2025-02-07 · Amgen Inc. · $13.94 · Open Payments source
REPATHA Normalized: repatha	Biological	Amgen Inc.	$13.94	1	2025
Source payment records 2025-02-07 · Amgen Inc. · $13.94 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
Amgen Inc. Exact reporting entity; no affiliate inference	2025	PROLIA open payments reported associated product	CMS Open Payments — General Payments 20867 supporting records · 11744 recipient NPIs · example record 1226874448	Prolia · 2024 Exact normalized brand match · 1 Part D row	19	suppressed by CMS

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1427	417
Levothyroxine Sodium	Levothyroxine Sodium	1044	274
Amlodipine Besylate	Amlodipine Besylate	881	249
Metformin Hcl	Metformin Hcl	584	181
Lisinopril	Lisinopril	568	165
Losartan Potassium	Losartan Potassium	562	161
Rosuvastatin Calcium	Rosuvastatin Calcium	558	170
Omeprazole	Omeprazole	488	140
Metoprolol Succinate	Metoprolol Succinate	397	113
Ezetimibe	Ezetimibe	375	109
Citalopram Hbr	Citalopram Hydrobromide	358	101
Tamsulosin Hcl	Tamsulosin Hcl	340	102
Hydrochlorothiazide	Hydrochlorothiazide	327	96
Prednisone	Prednisone	312	239
Simvastatin	Simvastatin	311	87
Pantoprazole Sodium	Pantoprazole Sodium	298	89
Allopurinol	Allopurinol	285	82
Gabapentin	Gabapentin	281	99
Alprazolam	Alprazolam	240	72
Trazodone Hcl	Trazodone Hcl	230	64
Metoprolol Tartrate	Metoprolol Tartrate	199	57
Azithromycin	Azithromycin	189	161
Mounjaro	Tirzepatide	179	29
Eliquis	Apixaban	178	60
Zolpidem Tartrate	Zolpidem Tartrate	178	57
Furosemide	Furosemide	175	60
Sertraline Hcl	Sertraline Hcl	174	46
Alendronate Sodium	Alendronate Sodium	170	45
Atenolol	Atenolol	169	47
Doxycycline Monohydrate	Doxycycline Monohydrate	164	141
Montelukast Sodium	Montelukast Sodium	160	54
Pravastatin Sodium	Pravastatin Sodium	157	43
Jardiance	Empagliflozin	155	45
Ozempic	Semaglutide	152	29
Ciprofloxacin Hcl	Ciprofloxacin Hcl	151	122
Clopidogrel	Clopidogrel Bisulfate	151	43
Meloxicam	Meloxicam	147	48
Synthroid	Levothyroxine Sodium	140	42
Escitalopram Oxalate	Escitalopram Oxalate	139	45
Hydralazine Hcl	Hydralazine Hcl	134	32
Carvedilol	Carvedilol	131	38
Donepezil Hcl	Donepezil Hcl	127	33
Bupropion Xl	Bupropion Hcl	122	42
Famotidine	Famotidine	120	38
Finasteride	Finasteride	111	33
Albuterol Sulfate Hfa	Albuterol Sulfate	98	39
Potassium Chloride	Potassium Chloride	96	32
Januvia	Sitagliptin Phosphate	90	24
Valsartan	Valsartan	89	24
Xarelto	Rivaroxaban	88	26
Duloxetine Hcl	Duloxetine Hcl	86	26
Spironolactone	Spironolactone	85	27
Temazepam	Temazepam	84	23
Nitrofurantoin	Nitrofurantoin Macrocrystal	82	78
Fenofibrate	Fenofibrate	74	23
Glimepiride	Glimepiride	74	22
Glipizide	Glipizide	74	25
Fenofibrate	Fenofibrate,micronized	71	22
Lorazepam	Lorazepam	70	24
Olmesartan Medoxomil	Olmesartan Medoxomil	68	24
Warfarin Sodium	Warfarin Sodium	67	14
Mupirocin	Mupirocin	66	49
Vascepa	Icosapent Ethyl	65	24
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	63	54
Farxiga	Dapagliflozin Propanediol	62	15
Fluoxetine Hcl	Fluoxetine Hcl	62	17
Oxybutynin Chloride	Oxybutynin Chloride	55	19
Benazepril Hcl	Benazepril Hcl	53	15
Tramadol Hcl	Tramadol Hcl	53	18
Propranolol Hcl	Propranolol Hcl	52	14
Sildenafil Citrate	Sildenafil Citrate	51	13
Ramipril	Ramipril	49	13
Venlafaxine Hcl Er	Venlafaxine Hcl	49	15
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	48	13
Clonazepam	Clonazepam	46	15
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	46	26
Glipizide Er	Glipizide	46	12
Metformin Hcl Er	Metformin Hcl	46	16
Nifedipine Er	Nifedipine	46	17
Fluticasone Propionate	Fluticasone Propionate	43	18
Ibuprofen	Ibuprofen	43	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	43	12
Myrbetriq	Mirabegron	41	14
Meclizine Hcl	Meclizine Hcl	40	17
Mirtazapine	Mirtazapine	40	12
Paroxetine Hcl	Paroxetine Hcl	40	14
Hydrocortisone	Hydrocortisone	39	14
Lovastatin	Lovastatin	39	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	39	suppressed
Valacyclovir	Valacyclovir Hcl	38	18
Buspirone Hcl	Buspirone Hcl	37	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	37	15
Glyburide	Glyburide	37	15
Tradjenta	Linagliptin	36	suppressed
Repatha Sureclick	Evolocumab	35	13
Torsemide	Torsemide	35	16
Ondansetron Hcl	Ondansetron Hcl	34	12
Amoxicillin	Amoxicillin	33	28
Dropsafe Prep Pads	Alcohol Antiseptic Pads	33	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	33	suppressed
Nebivolol Hcl	Nebivolol Hcl	33	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	32	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	32	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	32	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	31	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	31	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	31	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	31	24
Enalapril Maleate	Enalapril Maleate	30	suppressed
Colesevelam Hcl	Colesevelam Hcl	28	suppressed
Pregabalin	Pregabalin	28	suppressed
Nexlizet	Bempedoic Acid/Ezetimibe	27	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	26	suppressed
Icosapent Ethyl	Icosapent Ethyl	25	suppressed
Testosterone Cypionate	Testosterone Cypionate	25	suppressed
Breo Ellipta	Fluticasone/Vilanterol	24	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	24	15
Verapamil Er	Verapamil Hcl	22	suppressed
Bupropion Hcl Sr	Bupropion Hcl	21	suppressed
Folic Acid	Folic Acid	21	suppressed
Ibu	Ibuprofen	21	suppressed
Latanoprost	Latanoprost	21	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	21	suppressed
Ropinirole Hcl	Ropinirole Hcl	21	suppressed
Amiodarone Hcl	Amiodarone Hcl	20	suppressed
Cephalexin	Cephalexin	20	17
Clonidine Hcl	Clonidine Hcl	20	suppressed
Fluconazole	Fluconazole	20	15
Terazosin Hcl	Terazosin Hcl	20	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	19	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	19	suppressed
Digoxin	Digoxin	19	suppressed
Indapamide	Indapamide	19	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Prolia	Denosumab	19	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	18	suppressed
Estradiol	Estradiol	18	suppressed
Labetalol Hcl	Labetalol Hcl	18	suppressed
Lactulose	Lactulose	18	15
Methenamine Hippurate	Methenamine Hippurate	18	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	18	suppressed
Ondansetron Odt	Ondansetron	18	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	18	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	17	suppressed
Irbesartan	Irbesartan	17	suppressed
Lamotrigine	Lamotrigine	17	suppressed
Megestrol Acetate	Megestrol Acetate	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Topiramate	Topiramate	17	suppressed
Entresto	Sacubitril/Valsartan	16	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	16	suppressed
Tresiba Flextouch U-100	Insulin Degludec	16	suppressed
Ventolin Hfa	Albuterol Sulfate	16	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	15	suppressed
Bumetanide	Bumetanide	15	suppressed
Diazepam	Diazepam	15	suppressed
Imipramine Hcl	Imipramine Hcl	15	suppressed
Ipratropium Bromide	Ipratropium Bromide	15	suppressed
Metronidazole	Metronidazole	15	12
Telmisartan	Telmisartan	15	suppressed
Anastrozole	Anastrozole	14	suppressed
Celecoxib	Celecoxib	14	suppressed
Edarbi	Azilsartan Medoxomil	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	14	suppressed
Raloxifene Hcl	Raloxifene Hcl	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	13	suppressed
Aspirin-Dipyridamole Er	Aspirin/Dipyridamole	13	suppressed
Dutasteride	Dutasteride	13	suppressed
Ranolazine Er	Ranolazine	13	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	12	suppressed
Desmopressin Acetate	Desmopressin Acetate	12	suppressed
Fenofibric Acid	Fenofibric Acid (Choline)	12	suppressed
Haloperidol	Haloperidol	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Naproxen	Naproxen	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Praluent Pen	Alirocumab	12	suppressed
Serevent Diskus	Salmeterol Xinafoate	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Arnuity Ellipta	Fluticasone Furoate	11	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Gemtesa	Vibegron	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Liothyronine Sodium	Liothyronine Sodium	11	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	11	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$13.94 · 1 records	Amgen Inc.	OTEZLA, REPATHA	1	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

How do you evaluate evidence when you have a financial relationship with Amgen Inc.?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error